Literature DB >> 23317612

Clinical characteristics and surgical modality of plasma cell mastitis: analysis of 91 cases.

Jia Ming1, Gang Meng, Qiaoying Yuan, Ling Zhong, Peng Tang, Kongyong Zhang, Qingqiu Chen, Linjun Fan, Jun Jiang.   

Abstract

The objective of this study was to investigate the clinical characteristics and surgical modality of plasma cell mastitis (PCM). A total of 93 breasts of 91 female patients with PCM from June 2003 to June 2010 (unilateral in 89 patients and bilateral in two patients) were investigated in this study. All breasts were divided into two groups: the direct excision group (DE group) received focused excision and nipple retraction correction; and the incision drainage group (ID group) received these procedures only in the event of failing at least two incision drainages. Clinical characteristics, extent of excision, and prognosis were compared between two groups. There were 53 breasts in the DE group and 40 breasts in the ID group. No significant differences were noted in the number of retracted nipples and abscesses in the first visit or extent of disease between two groups (P > 0.05). However, during surgery, 3.85 ± 0.97 abscesses per breast were detectable in the ID group, which was significantly higher than 1.21 ± 0.06 abscesses per breast in the DE group. The ID group had significantly higher inflammation and excised extent compared with the DE group (P < 0.05). Hospitalization time was 179.60 ± 14.8 days in the ID group, which was significantly higher than 22.49 ± 1.93 days in the DE group (P < 0.05). Bacterial culture was negative for pus of 39 nonrupturing abscesses. Congenital nipple retraction may be the primary cause of PCM. Early and complete focused excision and nipple retraction correction are effective treatment methods.

Entities:  

Mesh:

Year:  2013        PMID: 23317612

Source DB:  PubMed          Journal:  Am Surg        ISSN: 0003-1348            Impact factor:   0.688


  9 in total

1.  IL-6/STAT3 signaling pathway is activated in plasma cell mastitis.

Authors:  Yang Liu; Jian Zhang; Yu-Hui Zhou; Yi-Na Jiang; Wei Zhang; Xiao-Jiang Tang; Yu Ren; Shui-Ping Han; Pei-Jun Liu; Jing Xu; Jian-Jun He
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

2.  Treatments for Periductal Mastitis: Systematic Review and Meta-Analysis.

Authors:  Huiying Xu; Ruidong Liu; Yanli Lv; Zhenhua Fan; Weimin Mu; Qingzhong Yang; Hui Fu; Yi Li
Journal:  Breast Care (Basel)       Date:  2021-02-18       Impact factor: 2.860

Review 3.  Current Understanding and Management of Plasma Cell Mastitis: Can We Benefit from What We Know?

Authors:  Mengying Xing; Shichang Zhang; Xiaoming Zha; Jiexin Zhang
Journal:  Breast Care (Basel)       Date:  2021-10-06       Impact factor: 2.268

4.  Study the Mechanism of Gualou Niubang Decoction in Treating Plasma Cell Mastitis Based on Network Pharmacology and Molecular Docking.

Authors:  Zhaojing Wu; Qing Yang; Hongbo Ma
Journal:  Biomed Res Int       Date:  2022-06-15       Impact factor: 3.246

5.  Differential diagnosis of plasma cell mastitis and invasive ductal carcinoma using multiparametric MRI.

Authors:  Rong Chen; Baoquan Hu; Yulong Zhang; Caibao Liu; Lianhua Zhao; Yan Jiang; Yan Xu
Journal:  Gland Surg       Date:  2020-04

6.  Continuous postoperative negative pressure irrigation assisted mammaplasty in treating chronic refractory plasma cell mastitis.

Authors:  Hua Xu; Yan Jiang; Mingjuan Liao; Dongliang Li; Chenfang Zhu
Journal:  Gland Surg       Date:  2020-12

7.  Periductal Mastitis: An Inflammatory Disease Related to Bacterial Infection and Consequent Immune Responses?

Authors:  Lu Liu; Fei Zhou; Pin Wang; Lixiang Yu; Zhongbing Ma; Yuyang Li; Dezong Gao; Qiang Zhang; Liang Li; Zhigang Yu
Journal:  Mediators Inflamm       Date:  2017-01-15       Impact factor: 4.711

8.  Exosomes Play an Important Role in the Progression of Plasma Cell Mastitis via the PI3K-Akt-mTOR Signaling Pathway.

Authors:  Xiaohong Wang; Yong Han; Jian Liu; Yingzhe Zhang; Kai Cheng; Jiwei Guo; Qingqun Guo; Song Liu; Hongguang Sun; Yitong Hua; Guoqiang Zhang; Shujian Xu; Fengli Guo; Zhenlin Yang
Journal:  Mediators Inflamm       Date:  2019-06-09       Impact factor: 4.711

9.  Chinese herbal compound combined with western medicine therapy in the treatment of plasma cell mastitis: A protocol for systematic review and meta-analysis.

Authors:  Jindan Zhang; Jianzhong Xu; Jiao Zhang; Yun Ren
Journal:  Medicine (Baltimore)       Date:  2020-10-30       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.